Name | Sector | Analyst Name | Analyst Job Title | Star Rating | Date | |
---|---|---|---|---|---|---|
Ebos Group Ltd | Healthcare | Shane Ponraj | Equity Analyst | 13/06/2024 | ||
Sigma Healthcare Ltd | Healthcare | Shane Ponraj | Equity Analyst | 13/06/2024 | ||
Getinge AB Class B | Healthcare | Jay Lee | Senior Equity Analyst | 12/06/2024 | ||
Teleflex Inc | Healthcare | Jay Lee | Senior Equity Analyst | 12/06/2024 | ||
AptarGroup Inc | Healthcare | Jay Lee | Senior Equity Analyst | 12/06/2024 | ||
Chugai Pharmaceutical Co Ltd | Healthcare | Jay Lee | Senior Equity Analyst | 11/06/2024 | ||
Takeda Pharmaceutical Co Ltd | Healthcare | Jay Lee | Senior Equity Analyst | 11/06/2024 | ||
Daiichi Sankyo Co Ltd | Healthcare | Jay Lee | Senior Equity Analyst | 11/06/2024 | ||
Biomarin Pharmaceutical Inc | Healthcare | Karen Andersen | Strategist | 11/06/2024 | ||
Novo Nordisk A/S ADR | Healthcare | Karen Andersen | Strategist | 11/06/2024 | ||
Novo Nordisk A/S Class B | Healthcare | Karen Andersen | Strategist | 11/06/2024 | ||
Mettler-Toledo International Inc | Healthcare | Jay Lee | Senior Equity Analyst | 10/06/2024 | ||
Swedish Orphan Biovitrum AB | Healthcare | Karen Andersen | Strategist | 07/06/2024 | ||
Grifols SA ADR | Healthcare | Karen Andersen | Strategist | 07/06/2024 | ||
Grifols SA PRF PERPETUAL EUR 0.05 - Cls B | Healthcare | Karen Andersen | Strategist | 07/06/2024 | ||
Biogen Inc | Healthcare | Karen Andersen | Strategist | 07/06/2024 | ||
Fresenius SE & Co KGaA | Healthcare | Julie Utterback | Senior Equity Analyst | 05/06/2024 | ||
Elekta AB Class B | Healthcare | Alex Morozov | Regional Director | 05/06/2024 | ||
GSK PLC | Healthcare | Damien Conover | Sector Director | 03/06/2024 | ||
GSK PLC ADR | Healthcare | Damien Conover | Sector Director | 03/06/2024 |